Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
227,895,837
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
44,419,298
-
Shares change
-
-469,957
-
Total reported value, excl. options
-
$155,464,628
-
Value change
-
-$2,050,076
-
Put/Call ratio
-
36%
-
Number of buys
-
51
-
Number of sells
-
-59
-
Price
-
$3.50
Significant Holders of Vaxart, Inc. - Common Stock, $0.0001 par value per share (VXRT) as of Q2 2022
154 filings reported holding VXRT - Vaxart, Inc. - Common Stock, $0.0001 par value per share as of Q2 2022.
Vaxart, Inc. - Common Stock, $0.0001 par value per share (VXRT) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,419,298 shares
of 227,895,837 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include STATE STREET CORP (12,671,950 shares), BlackRock Inc. (9,183,831 shares), VANGUARD GROUP INC (6,645,613 shares), GEODE CAPITAL MANAGEMENT, LLC (2,225,496 shares), MORGAN STANLEY (1,165,019 shares), NORTHERN TRUST CORP (1,161,756 shares), D. E. Shaw & Co., Inc. (1,040,386 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (884,269 shares), CITADEL ADVISORS LLC (842,635 shares), and GOLDMAN SACHS GROUP INC (591,552 shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.